“Market Access is a complex field that cannot be restricted to health economics, pricing or comparative effectiveness. Teaching Market Access needs to respond to an increasing demand for knowledge and expertise by pharma companies that now have to integrate the process early in the development strategy of a drug or device.”

“Companies need efficient methods for analyzing the market and taking adequate decisions in an uncertain and complex competitive environment. The European Market Access diploma provides expertise in decision making tools.”

“The generation of evidence that will support market access requires an increasing access to sophisticated methodology. The complex system theory is a way to address this issue”